Gapping up
In reaction to strong earnings/guidance: N/A.
M&A news: POT +5.1% (has withdrawn its proposal to negotiate a transaction with K+S Aktiengesellschaft (KPLUF))
Select EU related names showing strength: TEF +4.1%, SNY +2.2%, PHG +1.8%, UN +1.7%, ASML +1.5%, SHPG +1.4%, STM +1%, CS +1%, CCL +0.9%
Select oil/gas related names showing strength: SDRL +3.7%, RDS.A +2.3%, AEG +1.9%, SSL +1.9%, BP +1.7%, E +1.7%, PBR +1.5%, CHK +1.4%, RIG +0.9%
Other news: ONCE +56.4% (announces positive top-line results from the Phase 3 pivotal trial of SPK-RPE65), WAVX +45.6% (Wave Systems and Silicon Application sign a three-year software license and distribution agreement for Trusted Platform Module software management and maintenance), ASTI +17.6% (announced the strategic expansion of the Company's relationship with Verizon Premium Wireless Retailer), WG +12.7% (Willbros Group to sell its Professional Services segment to TRC Companies (TRR) for $130 mln cash), ANIP +10% (announces $25 mln common stock buyback), TTM +4.4% (issues statement following Economic Times article suggesting a partnership with Peugeot (PEUGY) is in the works), GE +3.7% (Trian Fund Management confirms it has taken an ~$2.5 bln stake in GE, has periodically engaged in informal dialogue with GE's management team), SUNE +3.4% (announces a proposed series of actions to optimize business operations in alignment with current and future market opportunities, and accelerate cash flow positive operations), BSX +3.3% (receives FDA approval for the SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System), TWTR +1.8% (appoints Jack Dorsey, Co-Founder and interim Chief Executive Officer, as Chief Executive Officer), MU +1.6% (cont strength), ENDP +1.4% (TPG Group Holdings discloses 7.6% active stake in 13G filing), GILD +1.1% (receives FDA appoval for Letairis with Tadalafil), TSLA +0.8% (says it delivered 11,580 vehicles in Q3), F +0.8% (UAW Union reached bargaining deal with Ford (F) workers), ACOR +0.8% (enters into a settlement agreement with Actavis Laboratories)
In reaction to strong earnings/guidance: N/A.
M&A news: POT +5.1% (has withdrawn its proposal to negotiate a transaction with K+S Aktiengesellschaft (KPLUF))
Select EU related names showing strength: TEF +4.1%, SNY +2.2%, PHG +1.8%, UN +1.7%, ASML +1.5%, SHPG +1.4%, STM +1%, CS +1%, CCL +0.9%
Select oil/gas related names showing strength: SDRL +3.7%, RDS.A +2.3%, AEG +1.9%, SSL +1.9%, BP +1.7%, E +1.7%, PBR +1.5%, CHK +1.4%, RIG +0.9%
Other news: ONCE +56.4% (announces positive top-line results from the Phase 3 pivotal trial of SPK-RPE65), WAVX +45.6% (Wave Systems and Silicon Application sign a three-year software license and distribution agreement for Trusted Platform Module software management and maintenance), ASTI +17.6% (announced the strategic expansion of the Company's relationship with Verizon Premium Wireless Retailer), WG +12.7% (Willbros Group to sell its Professional Services segment to TRC Companies (TRR) for $130 mln cash), ANIP +10% (announces $25 mln common stock buyback), TTM +4.4% (issues statement following Economic Times article suggesting a partnership with Peugeot (PEUGY) is in the works), GE +3.7% (Trian Fund Management confirms it has taken an ~$2.5 bln stake in GE, has periodically engaged in informal dialogue with GE's management team), SUNE +3.4% (announces a proposed series of actions to optimize business operations in alignment with current and future market opportunities, and accelerate cash flow positive operations), BSX +3.3% (receives FDA approval for the SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System), TWTR +1.8% (appoints Jack Dorsey, Co-Founder and interim Chief Executive Officer, as Chief Executive Officer), MU +1.6% (cont strength), ENDP +1.4% (TPG Group Holdings discloses 7.6% active stake in 13G filing), GILD +1.1% (receives FDA appoval for Letairis with Tadalafil), TSLA +0.8% (says it delivered 11,580 vehicles in Q3), F +0.8% (UAW Union reached bargaining deal with Ford (F) workers), ACOR +0.8% (enters into a settlement agreement with Actavis Laboratories)
Analyst comments: FOLD +14.2% (upgraded to Buy from Neutral at Chardan Capital Markets), BLUE +5.2% (upgraded to Overweight from Equal-Weight at Morgan Stanley), MT +4.6% (upgraded to Buy from Sell at Citigroup), KERX +4.1% (upgraded to Equal-Weight from Underweight at Morgan Stanley), DB +3.4% (upgraded to Buy at Kepler), CNX +1.8% (upgraded to Hold from Sell at Deutsche Bank), KN +1.8% (upgraded to Overweight at a boutique firm), DPS +0.8% (upgraded to Buy from Hold at Evercore ISI), YHOO +0.6% (target raised to $41 at Axiom Capital)